- Home
- INFA vs ROIV Comparison
INFA vs ROIV Comparison
Compare INFA & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INFA
- ROIV
- Stock Information
- Founded
- INFA 1993
- ROIV 2014
- Country
- INFA United States
- ROIV United Kingdom
- Employees
- INFA N/A
- ROIV N/A
- Industry
- INFA EDP Services
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- INFA Technology
- ROIV Health Care
- Exchange
- INFA Nasdaq
- ROIV Nasdaq
- Market Cap
- INFA 5.6B
- ROIV 7.8B
- IPO Year
- INFA 2021
- ROIV N/A
- Fundamental
- Price
- INFA $24.42
- ROIV $10.99
- Analyst Decision
- INFA Hold
- ROIV Buy
- Analyst Count
- INFA 15
- ROIV 4
- Target Price
- INFA $26.21
- ROIV $17.50
- AVG Volume (30 Days)
- INFA 3.7M
- ROIV 7.3M
- Earning Date
- INFA 07-29-2025
- ROIV 08-07-2025
- Dividend Yield
- INFA N/A
- ROIV N/A
- EPS Growth
- INFA 215.78
- ROIV N/A
- EPS
- INFA 0.00
- ROIV N/A
- Revenue
- INFA $1,655,308,000.00
- ROIV $29,053,000.00
- Revenue This Year
- INFA $5.12
- ROIV $2.64
- Revenue Next Year
- INFA $4.76
- ROIV $378.09
- P/E Ratio
- INFA $3,824.02
- ROIV N/A
- Revenue Growth
- INFA 2.29
- ROIV N/A
- 52 Week Low
- INFA $15.65
- ROIV $8.73
- 52 Week High
- INFA $31.65
- ROIV $13.06
- Technical
- Relative Strength Index (RSI)
- INFA 77.02
- ROIV 44.75
- Support Level
- INFA $24.24
- ROIV $10.83
- Resistance Level
- INFA $24.40
- ROIV $11.82
- Average True Range (ATR)
- INFA 0.09
- ROIV 0.32
- MACD
- INFA -0.16
- ROIV -0.07
- Stochastic Oscillator
- INFA 82.05
- ROIV 16.24
About INFA Informatica Inc.
Informatica Inc provides artificial intelligence (AI) enabled data management products on a cloud native platform that connects, manages, and unifies data across multi-vendor, multi-cloud, and hybrid systems at an enterprise scale. The company's platform includes a suite of interoperable data management products that leverage the shared services and metadata of the underlying platform, including products for Data Catalog, Data Integration & Engineering, API & Application Integration, Data Quality and Observability, Master Data Management, Customer and Business 360 Applications, Governance, Access and Privacy, and Data Marketplace., allowing customers to track and understand their data. Geographically, the company generates maximum revenue from North America.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.